Azitra (AZTR) Convertible Debt (2022)
Azitra's (AZTR) quarterly Convertible Debt came in at $6.6 million in Q4 2022.
Azitra (AZTR) Convertible Debt (2022) Analysis & Trends
Azitra (AZTR) has 1 years of Convertible Debt data on file, last reported at $6.6 million in Q4 2022.
- Quarterly Convertible Debt changed N/A year-over-year to $6.6 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $6.6 million (changed N/A YoY) and the FY2022 annual result came in at $6.6 million, changed N/A from the prior year.
- Convertible Debt was little changed at $6.6 million in Q4 2022.
- In the past five years, Convertible Debt ranged from a high of $6.6 million in Q4 2022 to a low of $6.6 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.87 Bn | 78.87 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.40 Bn | 60.22 Bn | 1.37 Bn |
| 4 | Moderna | 59.36 Bn | 54.22 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.91 Bn | 28.60 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.17 Bn | 9.78 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Azitra | 2.61 Mn | 2.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 6.60 Mn |